login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
NOVO-NORDISK A/S-SPONS ADR (NVO) Stock News
USA
-
New York Stock Exchange
- NYSE:NVO -
US6701002056
-
ADR
47.86
USD
-0.13 (-0.27%)
Last: 12/5/2025, 8:04:00 PM
47.91
USD
+0.05 (+0.1%)
After Hours:
12/5/2025, 8:04:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NVO Latest News, Press Relases and Analysis
All
Press Releases
a day ago - By: Chartmill
Novo Nordisk (NYSE:NVO) Embodies Quality Investing Principles
8 days ago - By: Chartmill
Novo Nordisk A/S (NYSE:NVO) Offers a Strong Dividend and Sound Fundamentals
2 days ago - By: The Motley Fool
- Mentions:
MRK
PFE
BMY
LLY
Do These 3 Healthcare Stocks Need a Checkup?
2 days ago - By: The Motley Fool
- Mentions:
LLY
BIIB
ESAI
This Pharmaceutical Giant Fell by 10% After a Setback: Time to Sell the Stock?
3 days ago - By: Stocktwits
- Mentions:
SPY
DIA
PFE
LLY
Trump Administration Eases Investment Deadlines For Large Pharma Companies: Report
3 days ago - By: Zacks Investment Research
- Mentions:
LLY
VKTX
ADVM
LLY Trading Above 50 & 200-Day SMAs for 2 Months: How to Play the Stock
4 days ago - By: Zacks Investment Research
- Mentions:
LLY
AMGN
VKTX
Can LLY Strengthen Its Lead as GLP-1 Price Cuts Reshape the Market?
5 days ago - By: Stocktwits
Novo Nordisk Defends Semaglutide Alzheimer’s Trials After Studies Miss Goals
5 days ago - By: Zacks Investment Research
- Mentions:
LLY
PFE
VKTX
LLY Lowers Prices of Zepbound Vials for Cash Buyers on DTC Website
5 days ago - By: Zacks Investment Research
Here is What to Know Beyond Why Novo Nordisk A/S (NVO) is a Trending Stock
6 days ago - By: Stocktwits
- Mentions:
OMER
Omeros Corp Sells Immune-System Drug To Novo Nordisk In $2.1B Deal — Retail Shifts Focus To Narsoplimab FDA Call
6 days ago - By: Zacks Investment Research
- Mentions:
PFE
LLY
VKTX
VKTX Stock Rises 34% in Three Months: Here's What You Should Know
6 days ago - By: Stocktwits
- Mentions:
LLY
Eli Lilly Cuts Prices For Weight Loss Drug Zepbound To $299 A Month As It Takes On Novo Nordisk’s Wegovy
10 days ago - By: Zacks Investment Research
- Mentions:
PFE
LLY
Novo Nordisk or Pfizer: Which Healthcare Giant Is the Better Bet?
10 days ago - By: Zacks Investment Research
- Mentions:
PFE
LLY
VKTX
Novo Nordisk Seeks Extra-Fast Nod From FDA for Higher Dose of Wegovy
10 days ago - By: Stocktwits
- Mentions:
LABU
TEVA
ABBV
AZN
...
Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared
10 days ago - By: Stocktwits
- Mentions:
TEVA
LLY
GSK
PFE
...
JPMorgan Says 2027 Medicare Drug Prices Signal Up To 40% Cuts Ahead — Novo Nordisk And Teva Stand Out As Top Targets
11 days ago - By: Zacks Investment Research
- Mentions:
PFE
LLY
VKTX
NVO Stock Up as Amycretin Shows Strong Weight Loss in Type 2 Diabetes
11 days ago - By: Zacks Investment Research
- Mentions:
PFE
LLY
ABBV
AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights
11 days ago - By: Investor's Business Daily
- Mentions:
RY
RY.CA
TEVA
NBIX
...
Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied
11 days ago - By: Stocktwits
- Mentions:
LLY
VKTX
HIMS
HSBC
...
Retail Traders Crown Novo Nordisk As Long-Term Weight Loss King — Even As Eli Lilly Hits $1T And Viking Fans Tout ‘M&A Prize’
12 days ago - By: Stocktwits
- Mentions:
DFAX
APIE
Novo Nordisk’s Experimental GLP-1 Drug Shows Weight Loss, Blood Sugar Levels Reduction In Study
12 days ago - By: Chartmill
Novo Nordisk (NYSE:NVO) Presents a Compelling Case for Value Investors
12 days ago - By: Stocktwits
- Mentions:
HSBC
Novo Nordisk Stock Tumbles: HSBC Downgrades After ‘Lottery Ticket’ Alzheimer’s Bet Fails, But Retail Traders Call Selloff ‘Ridiculous’
13 days ago - By: Chartmill
- Mentions:
INSP
VIV
ENLV
OSCR
...
Wondering what's happening in today's pre-market session?
13 days ago - By: Zacks Investment Research
- Mentions:
LLY
VKTX
Will NVO's U.S. Price Cuts Boost Access & Revive Semaglutide Demand?
Please enable JavaScript to continue using this application.